Ventas (NYSE:VTR – Get Free Report) had its price objective lifted by equities researchers at Scotiabank from $80.00 to $93.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s target price suggests a potential upside of 7.38% from the stock’s current price.
Several other analysts also recently commented on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $93.00 price objective on shares of Ventas in a research note on Monday, February 9th. Argus set a $88.00 price target on Ventas in a research note on Tuesday, February 10th. Wells Fargo & Company lifted their price objective on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Weiss Ratings upgraded shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Finally, Citigroup boosted their price target on shares of Ventas from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Ventas presently has an average rating of “Moderate Buy” and an average target price of $87.73.
View Our Latest Stock Report on VTR
Ventas Stock Performance
Ventas (NYSE:VTR – Get Free Report) last announced its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the company posted $0.81 earnings per share. Ventas’s quarterly revenue was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Research analysts anticipate that Ventas will post 3.4 EPS for the current year.
Insider Buying and Selling
In other news, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the completion of the sale, the chief financial officer directly owned 138,434 shares in the company, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president directly owned 72,755 shares in the company, valued at $6,184,175. This trade represents a 32.81% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 86,106 shares of company stock valued at $6,931,397. Corporate insiders own 1.00% of the company’s stock.
Hedge Funds Weigh In On Ventas
Several hedge funds have recently bought and sold shares of VTR. NewEdge Advisors LLC boosted its position in Ventas by 856.1% during the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after purchasing an additional 7,097 shares in the last quarter. Empowered Funds LLC raised its stake in shares of Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after buying an additional 536 shares during the last quarter. Woodline Partners LP raised its stake in shares of Ventas by 46.8% during the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after buying an additional 11,739 shares during the last quarter. Focus Partners Wealth boosted its position in shares of Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after buying an additional 12,233 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its stake in Ventas by 19.0% in the 2nd quarter. Envestnet Asset Management Inc. now owns 372,054 shares of the real estate investment trust’s stock valued at $23,489,000 after acquiring an additional 59,522 shares during the last quarter. 94.18% of the stock is owned by hedge funds and other institutional investors.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- 3 Signs You May Want to Switch Financial Advisors
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Where to invest $1,000 right now
- Your Bank Account Is No Longer Safe
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
